Balchem Corporation has acquired Belgium-based specialty gases company Chemogas.
With this acquisition, Balchem significantly expands its geographic presence in the packaged ethylene oxide market, enabling the company to offer worldwide service and support to its medical device sterilisation customers.
The Chemogas sites in Europe and Asia will form a global network of facilities when combined with Balchem’s sites in the US, making Balchem a global leader in the critical supply of ethylene oxide to the medical device sterilisation industry.
Facilitated by majority shareholder Gilde Equity Management, Chemogas was carved-out of The Linde Group in 2016.
... to continue reading you must be subscribed